GH1 and neurodegenerative disease: The widespread presence of GHR in the CNS and the neurotrophic effects of GH, together with many reports of its novel clinical application to treat neurodegenerative diseases including Alzheimer’s disease, amyotrophic lateral sclerosis, Parkinson’s disease, and brain trauma (reviewed in Bianchi et al. [10]), clearly imply a therapeutic potential that is worthy of research and review (Table 1).